High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

NCT00287924 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: methotrexate
PROCEDURE: adjuvant therapy

Sponsor

Children's Cancer and Leukaemia Group